⚠ TERN is no longer actively traded. Data shown reflects verified historical relationships.
Supply Chain Intelligence

Terns Pharmaceuticals, Inc. Supply Chain

TERN supply chain intelligence for Terns Pharmaceuticals, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

TERN ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

4Suppliers
5Customers
2Debt Items
20Related Chains

Terns Pharmaceuticals, Inc. Suppliers

TickerNameConfidenceEvidence
HANSOH HANSOH 90% we granted an exclusive option to Hansoh to obtain an exclusive, sub-licensable and royalty-bearing license under certain patent and other intellectual property rights owned or controlled by us
CASPIANTERN-LLC CASPIANTERN-LLC 80% S-1 1/15/2021 10.15 10.16† Exclusive Option and License, dated as of July 27, 2020, by and among Terns Pharmaceuticals, Inc., Terns, Inc., CaspianTern LLC, Hansoh (Shanghai) Healthtech Co., Ltd. and …
HANSOH-SHANGHAI-HEALTHTECH-CO-LTD HANSOH-SHANGHAI-HEALTHTECH-CO-LTD 80% S-1 1/15/2021 10.15 10.16† Exclusive Option and License, dated as of July 27, 2020, by and among Terns Pharmaceuticals, Inc., Terns, Inc., CaspianTern LLC, Hansoh (Shanghai) Healthtech Co., Ltd. and …
IBIO iBio, Inc. 72% Reciprocal relationship from IBIO graph: Reciprocal relationship from TERN graph: Reciprocal relationship from IBIO graph: t of our agreement with them. Any of our drug candidates, therefore, may be …

Terns Pharmaceuticals, Inc. Customers

TickerNameConfidenceEvidence
MERCK-SHARP-DOHME-LLC MERCK-SHARP-DOHME-LLC 92% Terns entered into an Agreement and Plan of Merger with Merck Sharp & Dohme LLC, a New Jersey limited liability company, and Thailand Merger Sub, Inc., a Delaware corporation and wholly owned subsidi…
THAILAND-MERGER-SUB-INC THAILAND-MERGER-SUB-INC 92% Thailand Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Merck, was a party to the Agreement and Plan of Merger with Terns.
MERCK-CO-INC MERCK-CO-INC 90% Merck & Co., Inc., is the parent company of Merck Sharp & Dohme LLC and was involved in funding the acquisition through borrowings under a credit agreement.
IBIO iBio, Inc. 72% Reciprocal relationship from IBIO graph: Biohaven, Ltd., Structure Therapeutics, Inc., Viking Therapeutics, Inc., Veru Inc., Zealand Pharma A/S, Metsera, Inc., Terns Pharmaceuticals, Inc., Skye Biosc…
VKTX Viking Therapeutics, Inc. 72% Reciprocal relationship from VKTX graph: y a given regulatory authority, such regulatory authority will determine that any of our clinical trials comply with GCP regulations. In addition, our clinica…

Terns Pharmaceuticals, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
TERN-DEBT-12942 Xbrl Convertible 90% xbrl convertible detail from xbrl 2021-12-31.
TERN-DEBT Debt stack $919,000 90% Market cache reports total debt of $919,000.

Terns Pharmaceuticals, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Terns Pharmaceuticals, Inc..

Terns Pharmaceuticals, Inc. Ownership

HolderNameConfidenceEvidence
TERN-OWNER-MORGAN-STANLEY MORGAN STANLEY 90% 13F overlay lists MORGAN STANLEY as top holder; 325 tracked holders.

Terns Pharmaceuticals, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
CLDX Celldex Therapeutics, Inc. 100.00 2
SEPN Septerna, Inc. 100.00 1 ['spend']
GPCR Structure Therapeutics Inc. 100.00 2
VKTX Viking Therapeutics, Inc. 100.00 1 ['customer']
CRBP Corbus Pharmaceuticals Holdings, Inc. 100.00 2
IBIO iBio, Inc. 100.00 1 ['customer', 'supplier']
LGND Ligand Pharmaceuticals Incorporated 100.00 2
JSPR Jasper Therapeutics, Inc. 100.00 2
LLY Eli Lilly and Company 100.00 2
MBX MBX Biosciences, Inc. 100.00 2
BBIO BridgeBio Pharma, Inc. 100.00 2
TWST Twist Bioscience Corporation 50.00 2
MDGL Madrigal Pharmaceuticals, Inc. 50.00 2
SKYE Skye Bioscience, Inc. 50.00 2
MRK Merck & Co., Inc. 50.00 2
GLMD Galmed Pharmaceuticals Ltd. 50.00 2
JNJ Johnson & Johnson 50.00 2
KROS Keros Therapeutics, Inc. 50.00 2
WVE Wave Life Sciences Ltd. 50.00 2
RUBRYC RUBRYC 50.00 2
View TERN supply chain intel →

Explore the full interactive supply chain map for Terns Pharmaceuticals, Inc..

Open TERN supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map